Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1-2
pubmed:dateCreated
1996-2-6
pubmed:abstractText
Pfs16 is a sexual stage/sporozoite-specific antigen of Plasmodium falciparum and is a potential candidate for a sporozoite-neutralizing vaccine. To obtain more information on the function of Pfs16 and to investigate its role during transmission and hepatocyte invasion, immunization experiments were performed with both a Pfs16-specific recombinant vaccinia virus and virus-like particles produced in yeast composed of the hepatitis B surface antigen (HBsAg) and antigen Pfs16 fused to HBsAg. Upon transformation of yeast cells, harbouring a genomic copy of the HBsAg gene, with a plasmid carrying the fusion gene Pfs16-HBsAg (Pfs16-S) virus-like hybrid particles composed of HBsAg and Pfs16-S were formed of a size similar to those present in human sera after infection with the hepatitis B virus. Cells infected with recombinant Pfs16 vaccinia virus synthesized a polypeptide of approx. 16 kDa that reacted with a Pfs16-specific polyclonal antibody. Animals vaccinated with the yeast hybrid particles and/or recombinant vaccinia virus both produced Pfs16-specific antibodies. These antibodies showed no transmission-blocking activity, but they efficiently diminished or abolished in vitro invasion of sporozoites into human hepatoma cells (HepG2-A16) and primary human hepatocytes.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0166-6851
pubmed:author
pubmed:issnType
Print
pubmed:volume
72
pubmed:owner
NLM
pubmed:authorsComplete
N
pubmed:pagination
179-92
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:8538688-Amino Acid Sequence, pubmed-meshheading:8538688-Animals, pubmed-meshheading:8538688-Anopheles, pubmed-meshheading:8538688-Antibodies, Protozoan, pubmed-meshheading:8538688-Antibody Specificity, pubmed-meshheading:8538688-Antigens, Protozoan, pubmed-meshheading:8538688-Carcinoma, Hepatocellular, pubmed-meshheading:8538688-Cells, Cultured, pubmed-meshheading:8538688-Female, pubmed-meshheading:8538688-Hepatitis B Surface Antigens, pubmed-meshheading:8538688-Humans, pubmed-meshheading:8538688-Insect Vectors, pubmed-meshheading:8538688-Liver, pubmed-meshheading:8538688-Liver Neoplasms, pubmed-meshheading:8538688-Malaria Vaccines, pubmed-meshheading:8538688-Membrane Proteins, pubmed-meshheading:8538688-Mice, pubmed-meshheading:8538688-Molecular Sequence Data, pubmed-meshheading:8538688-Plasmodium falciparum, pubmed-meshheading:8538688-Rabbits, pubmed-meshheading:8538688-Recombinant Fusion Proteins, pubmed-meshheading:8538688-Saccharomyces cerevisiae, pubmed-meshheading:8538688-Tumor Cells, Cultured, pubmed-meshheading:8538688-Vaccines, Synthetic, pubmed-meshheading:8538688-Vaccinia virus
pubmed:year
1995
pubmed:articleTitle
Induction of Plasmodium falciparum sporozoite-neutralizing antibodies upon vaccination with recombinant Pfs16 vaccinia virus and/or recombinant Pfs16 protein produced in yeast.
pubmed:affiliation
Department of Molecular Biology, Faculty of Science, University of Nijmegen, The Netherlands.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, U.S. Gov't, Non-P.H.S., Research Support, Non-U.S. Gov't